trans

462 MEDICAL IMPLICATIONS
Marr, J.J. (1991). Purine analogs as chemotherapeutic
agents in leishmaniasis and American
trypanosomiasis. J. Lab. Clin. Med. 118, 111–119.
Meyerhoff, A. (1999). US Food and Drug Administration
approval of AmBisome (liposomal
amphotericin B) for the treatment of visceral
leishmanias. Clin. Infect. Dis. 28, 42–48.
Pearson, R.D. (1999). Agents active against parasites
and Pneumocystis carinii. In: Mandell, G.L.,
Bennett, J.E. and Dolin, R. (eds). Principles and
Practice of Infectious Diseases, 5th edition, New
York: Churchill Livingstone, pp. 505–539.
Pearson, R.D. (2001). Atovaquone/proguanil for
the treatment and prevention of malaria. Curr.
Infect. Dis. Reps 3, 47–49.
Pearson, R.D. (2002). Parasitic diseases: helminths.
In: Yamada, T., Alpers, D.H., Laine, L.,
Owyang, C. and Powell, D.W. (eds). Textbook
of Gastroenterology, 4th edition, Philadelphia:
Lippincott-Raven.
Shapiro, T.A. and Englund, P.T. (1990). Selective
cleavage of kinetoplast DNA minicircles promoted
by antitrypanosomal drugs. Proc. Natl.
Acad. Sci. USA 87, 950–954.
Slunt, K.M., Mann, B.J., Macdonald, T.L. and
Pearson, R.D. (1999). The therapeutic potential
of DNA topoisomerase II poisons in treating
leishmaniasis. Recent Res. Dev. Antimicrob. Agents
Chemother. 3, 357–370.
Sousa Estani, S., Segura, E.L., Ruiz, A.M. et al.
(1998). The efficacy of chemotherapy with benznidazole
in children in the indeterminate phase
of Chagas’ disease. Am.J.Trop.Med.Hyg. 59,
526–529.
Stead, A.M.W., Bray, P.G. and Edwards, I.G. et al.
(2001). Diamidine components: selective uptake
and targeting in Plasmodium falciparum. Mol.
Pharmacol. 59, 1298–1306.
Wellems, T.E. and Plowe, C.V. (2001). Chloroquineresistant
malaria. J. Infect. Dis. 184, 770–776.
MEDICAL APPLICATIONS